These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8822143)

  • 1. Activation of coagulation but normal fibrinolysis in patients with type IIA hyperlipoproteinemia.
    Avellone G; Di Garbo V; Cordova R; Abruzzese G; Rotolo G; De Simone R; Raneli G; Bompiani G
    Thromb Res; 1996 Jan; 81(2):277-82. PubMed ID: 8822143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
    Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
    Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation and fibrinolysis systems in primary hyperlipoproteinemias].
    Berent H; Uchman B
    Pol Arch Med Wewn; 1983 Sep; 70(3):131-4. PubMed ID: 6657492
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity of lipoprotein electrophoretic patterns in patients with type IIa hyperlipoproteinemia.
    Hoeg JM; Papadopoulos NM; Gregg RE; Brewer HB
    Clin Chem; 1983 Aug; 29(8):1459-62. PubMed ID: 6872203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample.
    Kwiterovich PO; Heiss G; Johnson N; Chase GA; Tamir I; Rifkind B
    Am J Epidemiol; 1982 Feb; 115(2):192-204. PubMed ID: 7058778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II].
    Bo M; Molaschi M; Neirotti M; Bonino F; Gottero M; Pedrazzini V; Mainardi S; Fabris F
    Recenti Prog Med; 1992 Apr; 83(4):189-93. PubMed ID: 1626110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein (a); a new 'independent' risk factor for atherosclerosis].
    van Rijn HJ; Erkelens DW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(15):730-4. PubMed ID: 1532850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood coagulation and fibrinolysis: an overview.
    Mosher DF
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and sepsis.
    Machado FR; Silva E
    Endocr Metab Immune Disord Drug Targets; 2006 Jun; 6(2):175-82. PubMed ID: 16787292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.
    Schwandt P; Weisweiler P
    Atherosclerosis; 1980 Mar; 35(3):301-6. PubMed ID: 6987993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of coagulation and fibrinolysis in blood from normal men and women.
    Brakman P; Albrechtsen OK; Astrup T
    Br J Haematol; 1966 Jan; 12(1):74-85. PubMed ID: 5906272
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J; Goy-Loeper J; Rouffy J
    Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation, fibrinolysis and woundhealing].
    ASTRUP T
    Med Nov; 1959 Oct; 42():1972-9. PubMed ID: 13794909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of coronary arterial thrombus formation and the roles of coagulation and fibrinolysis systems].
    Urano T
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():125-31. PubMed ID: 27534159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of procetofen on the lipoprotein profile in patients with type II hyperlipoproteinemia].
    Drouin P; Méjean L; Lambert D; Sauvanet JP; Debry G
    Med Welt; 1979 Dec; 30(50):1910-3. PubMed ID: 548697
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.